Common genetic mutations observed in AML include mutations in genes encoding transcription factors (e.g., RUNX1, CEBPA), signaling molecules (e.g., RAS), epigenetic modifiers (e.g., DNMT3A, IDH1/2), and tumor suppressors (e.g., TP53). The gene discussed is TP53; the disease is acute myeloid leukemia.